US FDA erratic approach to placebo-controlled trials after issuing an emergency use authorization for a COVID-19 vaccine. Dal-Re R. Vaccine 2021 Jan 20. pii: S0264-410X(21)00077.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Dal-Re R. US FDA erratic approach to placebo-controlled trials after issuing an emergency use authorization for a COVID-19 vaccine. Vaccine 2021 Jan 20. pii: S0264-410X(21)00077.
PMID: 33516602